moxifloxacin 5 MG/ML Ophthalmic Solution [Vigamox]
moxifloxacin
RxCUI: 404473
What the CMS Formulary Data Shows for moxifloxacin 5 MG/ML Ophthalmic Solution [Vigamox]
Per the CMS 2026 Part D formulary file, moxifloxacin 5 MG/ML Ophthalmic Solution [Vigamox] (RxNorm concept RXCUI 404473, generic name moxifloxacin) appears on 1 distinct formulary file spanning 2 Medicare Part D plan offerings - 0% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 1, with a cross-plan average of Tier 1.
Real-world access to moxifloxacin 5 MG/ML Ophthalmic Solution [Vigamox] depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 596,568 Part D beneficiaries filled moxifloxacin 5 MG/ML Ophthalmic Solution [Vigamox] in 2023, with total plan-and-beneficiary spending of $31,944,777 and an average per-beneficiary annual cost of $53.55. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry moxifloxacin 5 MG/ML Ophthalmic Solution [Vigamox] today.
Coverage Details
- Formularies covering
- 1
- Plans covering
- 2
- Coverage rate
- 0%
- Tier range
- Tier 1, Preferred Generic
- Average tier
- Tier 1, Preferred Generic
Restrictions
- Prior authorization required
- 0% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
2023 Medicare Spending
- Beneficiaries
- 596,568
- Total spending
- $31,944,777
- Avg per beneficiary
- $53.55
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering moxifloxacin 5 MG/ML Ophthalmic Solution [Vigamox]
2 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Hamaspik Medicare Choice (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $0 | NY |
| Hamaspik Medicare Select (HMO D-SNP) | HAMASPIK, INC. | T1 | No | $34.50 | NY |
Frequently Asked Questions
Is moxifloxacin 5 MG/ML Ophthalmic Solution [Vigamox] covered by Medicare Part D?
Yes, moxifloxacin 5 MG/ML Ophthalmic Solution [Vigamox] is covered by 2 Medicare Part D plans (0% of all Part D formularies).
What tier is moxifloxacin 5 MG/ML Ophthalmic Solution [Vigamox] on Medicare Part D plans?
moxifloxacin 5 MG/ML Ophthalmic Solution [Vigamox] averages Tier 1 across Part D plans, ranging from Tier 1 to Tier 1.
Does moxifloxacin 5 MG/ML Ophthalmic Solution [Vigamox] require prior authorization?
0% of Part D formularies require prior authorization for moxifloxacin 5 MG/ML Ophthalmic Solution [Vigamox]. Step therapy: 0%. Quantity limits: 0%.
How much does Medicare spend on moxifloxacin 5 MG/ML Ophthalmic Solution [Vigamox]?
In 2023, total Medicare Part D spending on moxifloxacin 5 MG/ML Ophthalmic Solution [Vigamox] was $31,944,777, covering 596,568 beneficiaries. The average spend per beneficiary was $53.55.
Read our methodology - how this data is sourced, computed, and verified.